热门资讯> 正文
CEL-SCI股价因拟议公开募股而下跌
2025-08-28 05:32
- CEL-SCI Corporation (NYSE:CVM) said on Wednesday that it intends to offer to sell shares of its common stock in a best-efforts public offering.
- All of the shares of common stock are being offered by the company.
- The company intends to use the net proceeds from this offering to fund the continued development of Multikine, for general corporate purposes, and working capital.
- Shares of CEL-SCI (NYSE:CVM) fell more than 24% in extended trading.
More on Cel-Sci
- CEL-SCI announces pricing of $5.7 million offering
- Seeking Alpha’s Quant Rating on Cel-Sci
- Historical earnings data for Cel-Sci
- Financial information for Cel-Sci
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。